MicroRNA26a inhibits cisplatin‐induced renal tubular epithelial cells apoptosis through suppressing the expression of transient receptor potential channel 6 mediated dynamin‐related protein 1
- 30 December 2019
- journal article
- research article
- Published by Wiley in Cell Biochemistry and Function
- Vol. 38 (4) , 384-391
Abstract
Acute kidney injury (AKI) is a common adverse reaction of the anticancer drug. Among these chemotherapeutic agents, cisplatin, an effective chemotherapeutic drug, is extensively applied to the treatment of solid tumours, yet various adverse reactions, especially AKI, often limit their use. However, the pathogenesis of AKI caused by cisplatin remains poorly clarified. Therefore, we tested whether microRNAs, which have been certified as key regulators of disease are involved in this process. AKI mouse and HK2 cells were treated with cisplatin. Annexin V/PI staining and cleaved caspase‐3 were used to assess apoptosis. Western blot analyses and qRT‐PCR were used to evaluate the protein and mRNA level of TRPC6 and DRP1. miR‐26a was remarkably decreased in cisplatin‐induced AKI and in cisplatin co‐cultured HK2 cells. Furthermore, we used a miR‐26a mimics in vitro and found that apoptosis was alleviated than that in the control cells. We further verified that miR‐26a protected against cisplatin‐induced cell apoptosis by acting on transient receptor potential channel 6 (TRPC6) which can regulate the expression of dynamin‐related protein 1 (DRP1), thus inhibited the mitochondrial apoptosis pathway. Therefore, the study unveiled that miR‐26a/TRPC6/DRP1 is a novel protective pathway in cisplatin‐induced AKI and may be targeted for the prevention and treatment of drug‐related renal injury.Significance of the Study: Our study found that miR‐26a was significantly downregulated during cisplatin‐induced AKI and during cisplatin co‐cultured HK2 cells. Further, in vitro we used miR‐26a mimic to intervene cells and found that apoptosis alleviated compared with control group. We further verified that miR‐26a protected cisplatin‐induced apoptosis by target transient receptor potential channel 6 (TRPC6) which can regulate the expression of dynamic‐related protein 1 (DRP1) and inhibit the mitochondrial apoptosis pathway. Thus, miR‐26a/TRPC6/DRP1 is a new protective pathway in cisplatin‐induced AKI and may be targeted for the prevention and treatment of drug‐related acute kidney injury.Keywords
Funding Information
- Natural Science Foundation of Jiangsu Province (BK20161437)
This publication has 37 references indexed in Scilit:
- High glucose induces podocyte apoptosis by stimulating TRPC6 via elevation of reactive oxygen speciesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2013
- Increased risk of death and de novo chronic kidney disease following reversible acute kidney injuryKidney International, 2012
- Chronic kidney disease after acute kidney injury: a systematic review and meta-analysisKidney International, 2012
- Calcium entry via TRPC6 mediates albumin overload-induced endoplasmic reticulum stress and apoptosis in podocytesCell Calcium, 2011
- TRPC6 channels and their binding partners in podocytes: role in glomerular filtration and pathophysiologyAmerican Journal of Physiology-Renal Physiology, 2010
- Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent modelsJournal of Clinical Investigation, 2009
- Diagnosis, Epidemiology and Outcomes of Acute Kidney InjuryClinical Journal of the American Society of Nephrology, 2008
- Cisplatin nephrotoxicity: Mechanisms and renoprotective strategiesKidney International, 2008
- Acute Kidney Injury, Mortality, Length of Stay, and Costs in Hospitalized PatientsJournal of the American Society of Nephrology, 2005
- Functional role of TRPC channels in the regulation of endothelial permeabilityPflügers Archiv - European Journal of Physiology, 2005